Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $254.5 million.

  • Mirum Pharmaceuticals' Non-Current Assets fell 9.50% to $254.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $254.5 million, marking a year-over-year decrease of 9.50%. This contributed to the annual value of $278.0 million for FY2024, which is 7.29% up from last year.
  • Latest data reveals that Mirum Pharmaceuticals reported Non-Current Assets of $254.5 million as of Q3 2025, which was down 6.57% from $272.4 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Non-Current Assets ranged from a high of $292.9 million in Q2 2024 and a low of $4.5 million during Q1 2021.
  • In the last 3 years, Mirum Pharmaceuticals' Non-Current Assets had a median value of $262.5 million in 2024 and averaged $242.1 million.
  • In the last 5 years, Mirum Pharmaceuticals' Non-Current Assets spiked by 2,736.93% in 2021 and then slumped by 59.95% in 2023.
  • Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Non-Current Assets stood at $128.1 million in 2021, then rose by 27.04% to $162.7 million in 2022, then skyrocketed by 59.26% to $259.1 million in 2023, then increased by 7.29% to $278.0 million in 2024, then fell by 9.50% to $254.5 million in 2025.
  • Its Non-Current Assets was $254.5 million in Q3 2025, compared to $272.4 million in Q2 2025 and $279.4 million in Q1 2025.